SI
TMO icon

Stephens Inc’s Thermo Fisher Scientific TMO Stock Holding History

Stephens Inc’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6M Buy
23,680
+1,869
+9% +$1.01M 0.15% 150
2025
Q4 		$12.6M Sell
21,811
-80
-0.4% -$45.2K 0.16% 141
2025
Q3 		$10.6M Sell
21,891
-4,313
-16% -$2.01M 0.14% 159
2025
Q2 		$10.6M Sell
26,204
-265
-1% -$111K 0.15% 154
2025
Q1 		$13.2M Buy
26,469
+963
+4% +$522K 0.19% 125
2024
Q4 		$13.3M Buy
25,506
+2
+0% +$1.1K 0.19% 121
2024
Q3 		$15.8M Sell
25,504
-1,312
-5% -$777K 0.22% 114
2024
Q2 		$14.8M Buy
26,816
+103
+0.4% +$59K 0.23% 107
2024
Q1 		$15.5M Buy
26,713
+2,147
+9% +$1.2M 0.24% 102
2023
Q4 		$13M Buy
24,566
+1,516
+7% +$734K 0.22% 108
2023
Q3 		$11.7M Sell
23,050
-10,307
-31% -$5.49M 0.22% 105
2023
Q2 		$17.4M Sell
33,357
-16,958
-34% -$9.15M 0.31% 78
2023
Q1 		$29M Buy
50,315
+3,118
+7% +$1.76M 0.56% 37
2022
Q4 		$26M Buy
47,197
+22,216
+89% +$11.8M 0.53% 39
2022
Q3 		$12.7M Buy
24,981
+472
+2% +$264K 0.27% 89
2022
Q2 		$13.3M Buy
24,509
+14,315
+140% +$7.88M 0.27% 87
2022
Q1 		$6.02M Sell
10,194
-256
-2% -$147K 0.1% 218
2021
Q4 		$6.97M Sell
10,450
-845
-7% -$528K 0.11% 213
2021
Q3 		$6.45M Sell
11,295
-886
-7% -$486K 0.1% 217
2021
Q2 		$6.14M Sell
12,181
-159
-1% -$75K 0.09% 236
2021
Q1 		$5.63M Buy
12,340
+169
+1% +$80.7K 0.09% 226
2020
Q4 		$5.67M Buy
12,171
+776
+7% +$364K 0.1% 213
2020
Q3 		$5.03M Sell
11,395
-178
-2% -$73.5K 0.1% 201
2020
Q2 		$4.19M Sell
11,573
-233
-2% -$78.1K 0.09% 231
2020
Q1 		$3.35M Buy
11,806
+931
+9% +$294K 0.09% 235
2019
Q4 		$3.53M Sell
10,875
-207
-2% -$62.8K 0.07% 290
2019
Q3 		$3.23M Sell
11,082
-783
-7% -$224K 0.07% 287
2019
Q2 		$3.48M Sell
11,865
-123
-1% -$33.9K 0.08% 280
2019
Q1 		$3.28M Buy
11,988
+69
+0.6% +$17.2K 0.08% 292
2018
Q4 		$2.67M Buy
11,919
+256
+2% +$60.1K 0.08% 293
2018
Q3 		$2.85M Buy
11,663
+133
+1% +$30.6K 0.07% 322
2018
Q2 		$2.39M Sell
11,530
-755
-6% -$160K 0.07% 294
2018
Q1 		$2.54M Buy
12,285
+1,798
+17% +$377K 0.09% 233
2017
Q4 		$1.99M Sell
10,487
-1,086
-9% -$208K 0.07% 267
2017
Q3 		$2.19M Buy
11,573
+941
+9% +$170K 0.08% 246
2017
Q2 		$1.85M Buy
10,632
+899
+9% +$151K 0.06% 304
2017
Q1 		$1.5M Buy
9,733
+3,525
+57% +$539K 0.05% 341
2016
Q4 		$876K Sell
6,208
-7,499
-55% -$1.11M 0.04% 389
2016
Q3 		$2.18M Sell
13,707
-257
-2% -$39.6K 0.1% 232
2016
Q2 		$2.06M Sell
13,964
-376
-3% -$55.5K 0.09% 238
2016
Q1 		$2.03M Sell
14,340
-679
-5% -$91K 0.1% 217
2015
Q4 		$2.13M Buy
15,019
+7,052
+89% +$941K 0.11% 200
2015
Q3 		$974K Sell
7,967
-8,101
-50% -$1.06M 0.05% 340
2015
Q2 		$2.08M Sell
16,068
-199
-1% -$25.9K 0.09% 244
2015
Q1 		$2.19M Buy
16,267
+1,991
+14% +$257K 0.1% 230
2014
Q4 		$1.79M Buy
14,276
+5,133
+56% +$624K 0.08% 241
2014
Q3 		$1.11M Buy
9,143
+1,976
+28% +$240K 0.06% 316
2014
Q2 		$846K Buy
7,167
+1,738
+32% +$205K 0.04% 361
2014
Q1 		$653K Buy
5,429
+1,178
+28% +$140K 0.04% 415
2013
Q4 		$473K Sell
4,251
-175
-4% -$17.4K 0.02% 526
2013
Q3 		$408K Sell
4,426
-695
-14% -$62.9K 0.02% 521
2013
Q2 		$433K Buy
+5,121
New +$426K 0.02% 458

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stephens Inc's TMO Position: Q1 2026 in Review

Stephens Inc increased its Thermo Fisher Scientific (TMO) stake by 8.6% in Q1 2026, buying an estimated $1.01M and bringing the position to 23,680 shares worth $11.6M. The position accounts for 0.15% of the portfolio, ranked #150.

Stephens Inc first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $29M in Q1 2023. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Stephens Inc held 23,680 shares of Thermo Fisher Scientific worth $11.6M as of Q1 2026.
  • Stephens Inc bought 1,869 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.01M.
  • Thermo Fisher Scientific made up 0.15% of Stephens Inc's portfolio in Q1 2026, its #150 holding.
  • Stephens Inc first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Stephens Inc's Thermo Fisher Scientific position peaked at $29M in Q1 2023.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Stephens Inc's 13F filing for Q1 2026, filed 28 Apr 2026.